Delivering clinical, operational, commercial, organisational and digital excellence for payors, hospital providers, medical device manufacturers, pharmaceuticals and life science organisations.
In an increasingly complex healthcare market, where there is finite funding, a challenge to the status quo from disruptive innovation, tighter regulations and a concerted move towards integrated care and new care models, we help our clients to position themselves to maximise the opportunities.
Our purpose, beyond preventative care, is to ensure the right patient is triaged and directed to right healthcare institution, at the right time for the right diagnosis and treatment, using the right medium of intervention (evidence-based), and at the right cost.
We do this by helping payors, hospital providers, medical device manufacturers, pharmaceuticals and life science organisations to design and implement innovative, data-driven and evidence-based solutions, underpinned by technology, to demonstrably improve patient outcomes, quality of life and overall healthcare experience, whilst optimising cost.
The Silent Toll: Highlighting the Surge in Non-Covid Excess Mortality Amongst the Young and Exploring Potential Causes
The Pandemic is now a memory, yet non-Covid deaths continue to rise, for reasons the UK’s top healthcare authorities are unable to explain. The UK government’s own data shows Excess Mortality spiked most significantly among young people in 2022 and 2023, and shows a substantial increase in deaths due to heart failure during the same period – in 2023 alone, 7 times more people died unexpectedly, for reasons unrelated to COVID, than died in the single worst night of the Blitz. We provide insights into the excess mortality trends, explore potential causes, and urge a proper and broader investigation of the true root causes.
Healthcare Payors
Health systems around the world are having to fund and commission care for an ageing population with an increasing number of comorbidities, which require more complex and integrated care, with finite resources.
We support Private Medical Insurers (PMIs) and public payors and commissioners – Integrated Care Systems (ICSs) to assess, design and implement innovative healthcare services across the care continuum that improves quality, patient outcomes and experience, whilst reducing costs.
Hospital Providers
Hospital Providers are increasingly playing in a disruptive (e.g., ambulatory care), competitive and highly regulated market, where overall demand, activity level and costs are rising, whilst reimbursements are going the opposite way.
Hospitals are constantly having to strategise and transform their operations to ensure inpatient and outpatient services can be performed in the most efficient and sustainable way.
We support private and public healthcare providers to design and implement data-driven clinical, operational, organisational and commercial transformations to ensure a sustainable future. Our clients benefit from a significant improvement in patient outcomes, patient and clinician experience, operational efficiency and profitability.
Medical Device, Pharma & Life Sciences
Medical Device manufacturers, together with Pharmaceuticals and Life Science organisations are operating in a complex, competitive, disruptive and highly regulated market, which varies significantly by country.
The manufacturers of devices, drugs and therapies are also increasingly facing a global push towards outcome-based reimbursement models, particularly in mature markets. At the same time, organisations are also trying to move closer to the patient to leverage big data to improve their products and services, and ultimately, drive towards personalised medicine.
In addition, payors, providers, clinicians and patients are becoming more sophisticated ‘consumers’ of healthcare products and services, so expectations are rising fast.
We help manufacturers of devices, drugs and therapies to maximise the opportunities, through new product launch, new market entry, with the motto of making healthcare available, accessible, and affordable for everyone and thereby help manufacturers move from the traditional low margin, short-term focus business to a high margin one with a focus on long term partnerships.
Private Equity
As the number of Private Equity firms continue to grow at a faster rate than the investment opportunities available, we help our PE clients on pre-acquisition, post-acquisition and implementation to drive value creation from their healthcare assets.
We leverage our vast clinical, operational and commercial expertise across the Healthcare value chain to drive value creation for our clients.
where we can help
Payors & Commissioners
We support Private and Public Payors and Commissioner clients on:
- Population Health assessment and impact on services
- Devolution of services and impact on Integrated Care Systems (ICSs)
- Service review
- Outline Business Case (OBC) development
- Full Business Case (FBC) development
- Pathway and/or service design / redesign
- Contract reviews and procurement
- Provider network design and procurement
- Project management of complex change or transformations
Hospital Providers
We support Private and Public Hospital Provider clients on:
- Growth strategy validation or development
- Operational transformation
- Clinical, Operational and Commercial excellence delivery
- Pathway and/or service design / redesign
- Procurement opportunity assessment and implementation
- Scheduling, theatre and bed ulitisation optimisation
- Digital strategy and implementation
- Digitalisation of Care Pathway
- Project management of complex change or transformations
Medical Device, Pharma & Life Science
We support Medical Device, Pharmaceuticals & Life Science clients on:
- Growth strategy validation or development
- Post-merge integration planning and execution
- Product launch strategy and implementation
- Operational transformation design and execution
- Manufacturing footprint strategy and execution
- Operating model design and execution
- Procurement opportunity assessment, organisation design and implementation
- Finance and Human Resources transformation
Private Equity
We support Private Equity clients on:
- Pre-deal target search and identification
- Due diligence and investment thesis validation
- Performance improvement
- 100-day planning design and execution
- Growth strategy validation or development
- Value proposition development
- Service and Operating Model design and implementation
- Post-merger integration
- Pre-exit operational improvement
Healthcare client results
Developing multiple pathways and identifying over £16m cost savings at a major health insurer
The Issue
- Pressure to increase efficiency in their claims due to rising medical costs
- Large variation in costs between suppliers and across the UK
- Lack of structured routing for members to effective treatments and cost-efficient providers across hospitals, clinics or doctors
- Poor cost control with growing pressure to tackle medical costs due to rising claims and pressure on margins
- Difficulty negotiating cost reductions with hospitals, and a huge number of suppliers (including doctors) to manage
Leveraging procurement to increase profitability of orthopaedic services
The Issue
- Many suppliers (18+) resulting in reduced spend leverage
- Prosthesis selection based on supplier systems familiarity not generic technical spec
- Large cost variances for similar hip and knee systems from supplier to supplier
- A large amount of “additional” costs associated with instrumentation and loan kits
- Huge variety in ‘same’ type of hip and knee systems (7+ systems for each)
- Too many system variations (75+) resulting in staff needing to be trained on many systems/brands
Healthcare insights
Virtual Care: delivering healthcare in the new reality
The global COVID-19 pandemic has caused widespread disruption around the world and bought with it a lot of uncertainty. The response from many healthcare systems is showing the increased adoption of digital tools and innovative solutions.
Read more…
Patient experience – the case for home dialysis
Blockchain in healthcare: a use case
Explore how Blockchain in healthcare will revolutionise the billing and payment process, resulting in the complete disintermediation of a vast administrative layer within the Healthcare Provider and Payer (private insurer or public commissioner) organisation.
Precision medicine – using data to prevent heart disease and stroke
Curzon Healthcare Lead Chetan Trivedi in conversation with Dr Rameen Shakur MD PhD (Cantab), Massachusetts Institute of Technology, Boston. We explore precision medicine, the importance of a patient-centric approach to data and how medical technology is improving healthcare accessibility.
Read more…
The convergence of healthcare and travel
Airports and the wider transportation industry are facing a number of new challenges as they prepare for the realities of a post COVID-19 world.
What our clients say
“The Curzon team have done an excellent job first assisting our global business and then with our UK team to strategically review our approach to procurement and spending benchmarks across our service lines. The strategy, supplier engagement, best practices and data have presented several enduring opportunities to strengthen our approach.”
CFO
Major Private Hospital Group
get in touch
ContactChetan TrivediPartner - Healthcare